Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK of Paracetamol Uniflash Buccal in Healthy Adults
NCT05406752Phase 1Completed
- Sponsor
- Unither Pharmaceuticals
- Start
- Jul 2022
- Primary completion
- Jul 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of acetaminophen in acute pain, sponsored by Unither Pharmaceuticals. Primary endpoints: Paracetamol Peak Plasma Concentration (Cmax) After Single Dose at 12 hours and Paracetamol Area Under the Plasma Concentration Versus Time Curve (AUC) After Single Dose at 12 hours. Started Jul 2022; status: completed.
02
Drugs
acetaminophen
03
Conditions
acute pain
Beyond the preview
Go deeper on NCT05406752.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05406752.